![]() Music |
![]() Video |
![]() Movies |
![]() Chart |
![]() Show |
![]() | Changes in NCCN Guideline: Affecting First-Line (OncLive) View |
![]() | NCCN Guidelines for Treatment of Localized Prostate Cancer (Grand Rounds in Urology) View |
![]() | NCCN Genetic/Familial Guideline Updates (V1.2023 u0026 V.1.2022) (Inherited Cancer Registry (ICARE)) View |
![]() | First-line Immunotherapy: IMPower133 Regimen (OncLive) View |
![]() | Next-generation sequencing (NGS): Modern lecture (DRdoubleB) View |
![]() | Hepatic/Biliary CA 2 I Case1: Biopsy I B: Seeding I 2: Pancreatic CA Mutation I 3: Fibrolamellar HCC (ACE_Oncology) View |
![]() | Improving Specificity of PSA Screening w/ Serum u0026 Urine Markers: Who Doesn’t Need a Prostate Biopsy (Grand Rounds in Urology) View |
![]() | CRSF 7th Masterclass | Hidden EGFR Threats u0026 Role of Amivantamab by Dr. Anshul Gupta | Day 3 (CRSF - Cancer Research and Statistic Foundation) View |
![]() | Ep 3 : Oncology Morning Commute: ADCs for NSCLC—Ready for Prime Time (AtPointOfCare) View |
![]() | Developing Lung Cancer Screening Guidelines - 2022 Gastric Cancer Summit (Stanford Department of Medicine) View |